Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
CONTINGENT EARN-OUT LIABILITY	$ 26,242	$ 30,409	$ 57,701			$ 26,242	$ 2,589
Business Combination, Consideration Transferred, Liabilities Incurred			55,158
Currency translation on earn-out	(108)	(98)	(46)
Pursuit Vascular, Inc. [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
CONTINGENT EARN-OUT LIABILITY	26,300			$ 26,300	$ 26,300	26,300		$ 26,300
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)				$ 0	$ 0
SmithsMedical
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Business Combination, Consideration Transferred, Liabilities Incurred			53,500			$ 53,520
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	$ (4,059)	$ (27,194)
Foreign Infusion System Supplier
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Business Combination, Consideration Transferred, Liabilities Incurred			$ 1,600